Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Novak

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 2023
Frentizole derivatives with mTOR inhibiting and senomorphic propertiesZofia Chrienova, David Rysanek, Josef Novak, et al.
ACS Pharmacology & Translational Science|September 19, 2024
Discovery of a 6-Aminobenzo[<i>b</i>]thiophene 1,1-Dioxide Derivative (K2071) with a Signal Transducer and Activator of Transcription 3 Inhibitory, Antimitotic, and Senotherapeutic ActivitiesPatrik Oleksak, David Rysanek, Marketa Vancurova, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 2023
Frentizole derivatives with mTOR inhibiting and senomorphic propertiesZofia Chrienova, David Rysanek, Josef Novak, et al.
ACS Pharmacology & Translational Science|September 19, 2024
Discovery of a 6-Aminobenzo[<i>b</i>]thiophene 1,1-Dioxide Derivative (K2071) with a Signal Transducer and Activator of Transcription 3 Inhibitory, Antimitotic, and Senotherapeutic ActivitiesPatrik Oleksak, David Rysanek, Marketa Vancurova, et al.
Pageof 2